Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG36969

H1-2 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The H1-2 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited mixed population of HAP1 near-haploid human cells harboring a targeted disruption of the H1-2 gene. This linker histone knockout model is designed for studying chromatin organization, p53-mediated apoptosis, and DNA damage responses. H1-2 interacts with nucleosomes and BAK to regulate gene expression and caspase activation. Derived from KBM-7 chronic myeloid leukemia cells, HAP1 cells offer a simplified genetic background ideal for functional genomics. This product supports assays such as ChIP-seq, Western blot, and flow cytometry for apoptosis, enabling advanced research in cancer biology and neurodevelopmental disorders.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    H1-2

    Gene Identifier

    NCBI Gene ID 3006

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

This product is a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HAP1 near-haploid human cell line, in which the H1-2 gene has been disrupted to create a loss-of-function model. The H1-2 gene encodes a linker histone that plays critical roles in chromatin organization, apoptosis regulation, and the DNA damage response. The polyclonal format provides a heterogeneous pool of gene-edited cells, enabling flexible experimental design and robust representation of genetic diversity. This knockout model is ideal for investigating the mechanistic contributions of H1-2 to cellular processes without the constraints of single-cell clonal isolation.

The HAP1 host cell line is a near-haploid human cell line originally derived from the KBM-7 chronic myeloid leukemia cell line. HAP1 cells exhibit an adherent, fibroblast-like morphology and are widely employed in functional genomics and genetic knockout screens due to their haploid karyotype, which simplifies gene targeting and phenotypic analysis. This background provides a human cellular context for studying gene function, with particular relevance to cancer biology and hematopoietic lineage research. The parental KBM-7 origin also links HAP1 cells to leukemia-associated signaling pathways, offering a disease-relevant platform.

H1-2 (histone H1.2) is a member of the linker histone family that binds to nucleosomes and promotes higher-order chromatin compaction. Mechanistically, H1-2 is regulated by p53 and cyclin-dependent kinases in response to DNA damage signals. It interacts with nucleosomes, DNA, and chromatin remodeling complexes to globally influence gene expression. During apoptosis, H1-2 is released from mitochondria and contributes to p53-mediated transcriptional activation of pro-apoptotic factors such as BAK, thereby engaging caspase-dependent execution pathways. This positions H1-2 at the intersection of chromatin dynamics and programmed cell death signaling.

In the HAP1 cellular context, disruption of H1-2 enables precise dissection of linker histone functions in chromatin organization and apoptosis. This knockout model is particularly valuable for studying p53-dependent apoptosis mechanisms, DNA damage response pathways, and the role of linker histones in leukemia and other cancers. The near-haploid nature of HAP1 cells reduces genetic complexity, allowing clear attribution of phenotypic changes to H1-2 loss. Moreover, the model facilitates investigation into neurodevelopmental disorders linked to H1-2 dysfunction, supporting translational research efforts.

Researchers can apply this knockout cell population in a variety of assays, including ChIP-seq for genome-wide chromatin profiling, Western blot and immunofluorescence for protein analysis, caspase activity assays and flow cytometry for apoptosis quantification, RT-qPCR for gene expression studies, and colony formation assays to assess cellular fitness. This product is optimized for use in chromatin biology, apoptosis research, and cancer genetic screens. For further technical details or bespoke services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)